Stanford professor Russ Altman acknowledges that startups often fear regulators, but insists that in the biotech space, the FDA is keen to work with companies to bring products to market and advise startups as part of an open dialogue. In the context of AI-driven drug development, GSK senior VP and Global Head of AI/ML Kim Branson adds, an evolving conversation between industry and government will lead to new ways of ensuring the safe delivery of cutting-edge therapies.
Related

Sarah Lamaison,
Dioxycle
Climate Tech Insights [Entire Talk]
Climate tech entrepreneurs are an essential part of reducing and removing carbon emissions.
Video
47 minutes
Sarah Lamaison,
Dioxycle
Climate Tech Insights [Entire Talk]
Climate tech entrepreneurs are an essential part of reducing and removing carbon emissions.

Michelle Lee,
Medra
From Conviction to Company [Entire Talk]
From finding conviction in their ideas to deciding how to grow, detect founders face many decisions.
Video
49 minutes
Michelle Lee,
Medra
From Conviction to Company [Entire Talk]
From finding conviction in their ideas to deciding how to grow, detect founders face many decisions.

Andy Dunn,
Bonobos
Mental Health for Entrepreneurs [Entire Talk]
Mental health matters for entrepreneurs — and everyone
Video
51 minutes
Andy Dunn,
Bonobos
Mental Health for Entrepreneurs [Entire Talk]
Mental health matters for entrepreneurs — and everyone